-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
-
Men 2010: 12th International…
16–18 September, 2010
This two-day meeting will provide a forum for educating basic and clinical…
-
Ribonuclease H2010
20–22 September, 2010
We expect to bring together scientists interested in making as much…
-
Third Annual Ultra Orphan…
27–29 September, 2010
Centric Health Resources Presents Third Annual Ultra Orphan Conference…
-
Brain, Blood and Iron: Joint…
1–2 October, 2010
The overall objectives of this workshop are to (1) define NA and NBIA…
Events
-
Study Explains Why Alzheimer's Drug Is Both Safe and Effective
Thursday, August 19, 2010
Alzheimer's disease destroys brain cells and their connections (called synapses), causing memory loss and other cognitive problems that disrupt work, hobbies and daily lifeSymptoms can be alleviated, in part, by the drug memantine (marketed in the United States as Namenda), which is currently FDA-
-
Study Sheds Light on Cancer-Causing Gene Regulation
Wednesday, August 18, 2010
BOSTON -- Researchers at Beth Israel Deaconess Medical Center (BIDMC) have uncovered the genes that regulate MDM2, an oncogene that, in turn, regulates the tumor suppressor protein p53But instead of an on-off switch for MDM2, the team found what looks like a dimmer switch, suggesting a more compli
-
Evolution May Have Pushed Humans Toward Greater Risk for Type 1 Diabetes, Stanford Study Shows
Wednesday, August 18, 2010
STANFORD, Calif. -- Gene variants associated with an increased risk for type-1 diabetes and rheumatoid arthritis may confer previously unknown benefits to their human carriers, say researchers at the Stanford University School of MedicineAs a result, the human race may have been evolving in the re
-
TAU Develops Genetically Mutated Stem Cells for Myelin Research
Wednesday, August 18, 2010
Vanishing White Matter (VWM) disease is a devastating condition that involves the destruction of brain myelin due to a mutation in a central factorTo understand the disease and test potential treatments that could apply to other disorders, such as multiple sclerosis, Prof. Orna Elroy-Stein of Tel
-
New Mechanisms of Tumor Resistance to Targeted Therapy in Lung Cancer Are Discovered
Wednesday, August 18, 2010
Cold Spring Harbor, NY -- One of the most tantalizing developments in anti-cancer therapy over recent years has been the advent of targeted treatments, which have proven highly effective in holding aggressive cancers at bay in certain patients, although typically only for a limited period of timeA
-
ISU Researchers Discover Cause of Immune System Avoidance of Certain Pathogens
Wednesday, August 18, 2010
AMES -- A special set of sugars found on some disease-causing pathogens helps those pathogens fight the body's natural defenses as well as vaccines, say two Iowa State University researchersThis discovery may be a first step in understanding a disease family that includes tuberculosis for which th
-
Boston University, Veterans Affairs Find Sports Brain Trauma May Cause Disease Mimicking ALS
Wednesday, August 18, 2010
BOSTON -- The Center for the Study of Traumatic Encephalopathy (CSTE) at Boston University School of Medicine (BUSM) and Department of Veterans Affairs (VA) announced today that they have provided the first pathological evidence that repetitive head trauma experienced in collision sports is The mo
-
Gallbladder Cancer May Be Linked to Estrogens, Says UH Team
Tuesday, August 17, 2010
HOUSTON -- A very aggressive disease with a poor prognosis, gallbladder cancer may be connected to higher exposure to estrogens, according to a group of researchers at the University of Houston (UHDr. Jan-Åke Gustafsson, Robert A. Welch Professor in UH's biology and biochemistry department,
-
Scientists Reveal New Targets for Anti-Angiogenesis Drugs
Tuesday, August 17, 2010
BOSTON -- A new study describes how a carbohydrate-binding protein, galectin-3, promotes angiogenesis, the growth of new blood vesselsTargeting the protein, scientists identified two approaches that significantly reduced angiogenesis in mice. These discoveries, published online August 16 in The Jo
-
Sensing a Breakthrough
Tuesday, August 17, 2010
When researchers pinpointed the genetic mutation that leads to the disease known as facioscapulohumeral dystrophy (FSHD) in 1992, hopes rose that the discovery not only would result in better treatments but also eventually a cure for the diseaseBut FSHD, which was first described by French physici
